Sysmex touts advanced clinical parameters
Sysmex America has launched an educational section on its website that aims to provide information to laboratory professionals about the company’s Advanced Clinical Parameters, which are tests that provide additional information about the state of blood cells. ACPs expand the complete blood count laboratory test and aid in the detection of several hematological conditions.
“The clinicians and physicians who are already using our ACPs have found them helpful in detecting and differentiating a wide variety of hematological conditions, including anemia, infection, inflammation, and potentially life-threatening conditions,” Jolanta Kunicka, PhD, Sysmex’s director scientific marketing, said in a statement.
The new website sections include a wide variety of information about Sysmex ACPs. That includes how advanced quantitative measurement of immature granulocyte populations may identify left shift and improve the assessment of infections and inflammation. There is an incremental savings associated with automated accurate IG count versus traditional manual methodologies.
The website also covers how to evaluate and monitor acute changes in hemoglobinization at the cellular level for earlier detection of iron deficiency anemia using reticulocyte hemoglobin. This advanced parameter has been used by physicians in identifying and managing anemia in high-risk populations such as young children, patients with chronic disease, presurgical patients, and cancer patient populations.
The Sysmex site provides information on how immature platelet fraction can be used to more specifically assess and monitor thrombocytopenia, particularly in cancer and pediatric patients.